Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)
| Conditions: | Lung Cancer|Mesothelioma|Malignant Airway Obstruction |
| Start Date: | October 1, 2008 |
| Phase: | Phase IV |
| Status: | Terminated |
| NCT ID: | NCT00748085 |
| Study Type: | Interventional |
| Intervention: | Device: CryoSpray Ablation (TM) System |
| Study Design: | Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | CSA Medical, Inc. |
| Ages: | Adult|Senior |
| Enrollment: | 5 |
| Funded By: | Industry |
| First Received: | September 4, 2008 |
| End Date: | August 1, 2009 |
| Last Updated: | August 17, 2010 |
| Last Verified: | August 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
